Medicare Part B pays for outpatient lab work only when a qualified provider orders the test to diagnose or treat a documented medical condition, and it draws sharp lines around routine screening panels, tests that have already hit their allowed frequency, and orders missing clear clinical justification.
This resource explains how conditional coverage rules shape denials, which specific blood panels beneficiaries most often see rejected, and what out-of-pocket costs to expect when Medicare declines to pay.
The Conditional Nature of Medicare Blood Test Coverage
Medicare Part B pays for outpatient clinical laboratory services only when a physician, nurse practitioner, or other qualified provider orders the test for the diagnosis or treatment of a specific medical condition. The Social Security Administration defines “medical necessity” narrowly: the lab work must be reasonable, necessary for your care, and ordered by a provider who treats you for that condition. A wellness panel ordered “just to check,” without a symptom, diagnosis, or follow-up question, is the first place coverage collapses.
Two regulatory layers govern every claim the lab files. National Coverage Determinations, issued by CMS, set nationwide rules for individual tests and tell every Medicare Administrative Contractor the same thing at once. Local Coverage Determinations add regional medical-necessity criteria that vary by state and contractor, which is why a lipid panel covered in Florida can be denied in Oregon for the same diagnosis code. Coverage status also shifts whenever CMS updates clinical guidelines, so a test paid for last year can be excluded the next.
Why a “covered” test can still leave you with a bill
Even tests Medicare explicitly covers can produce a charge when the order lacks a matching ICD-10 code, when the Part B deductible hasn’t been met, or when the lab is out of network under Medicare Advantage. The test itself isn’t the variable; the documentation and setting are. Many denied claims trace back to a doctor’s office that wrote “fatigue” instead of a code the contractor recognizes for that specific assay.
Tip: Ask the ordering provider’s office to print the exact ICD-10 diagnosis code on the requisition, not just the symptom name. Carrying that five-character code to the lab visit can prevent the most common category of denials.
| Decision Layer | Who Issues It | Scope |
|---|---|---|
| National Coverage Determination (NCD) | CMS headquarters | Applies to every state and contractor |
| Local Coverage Determination (LCD) | Medicare Administrative Contractor | Applies to a defined region or state |
| Claim edit / frequency limit | Medicare claims system | Automatic denial past the allowed interval |
| Medical-necessity review | Contractor or Recovery Audit Contractor | Post-payment review of documentation |
Three Distinct Categories of Denial Medicare Beneficiaries Encounter
Most lab denials fall into one of three buckets, and each triggers a different billing code, denial reason, and patient liability amount. Knowing which bucket applies tells you whether the bill can be appealed, written off, or simply paid.
Non-covered services
Some tests are excluded by statute or by a National Coverage Determination regardless of how sick you are. Most vitamin D screening in asymptomatic adults sits in this bucket, as do broad-panel allergy IgE tests ordered without a documented allergic history and tumor markers such as CA-125 used outside USPSTF guidelines. The Claim Adjustment Reason Code on your Medicare Summary Notice will usually read “non-covered service” or “not covered under Medicare,” and the lab is allowed to bill you its full undiscounted rate.
Frequency-limited tests
Other tests are covered, but only at specified intervals. Hemoglobin A1C for a non-diabetic patient is paid once every 12 months; a lipid panel for a low-risk adult follows a five-year screening window. Repeat the test earlier and Medicare pays nothing, even when a doctor ordered it. The denial reason typically cites the frequency edit, not medical necessity, which makes this category the easiest to predict before the draw.
Medical-necessity denials
The trickiest category covers tests Medicare would otherwise pay for, but where the documentation doesn’t link the order to a covered condition. A TSH drawn for “fatigue” without thyroid symptoms on file can be denied if the local LCD lists only known thyroid disease as a payable indication. The remedy is a stronger letter of medical necessity from the ordering provider, not a new lab order.
| Denial Category | Why It’s Denied | Can It Be Appealed? |
|---|---|---|
| Non-covered service | Excluded by statute or NCD | Yes, but rarely successful |
| Frequency limit | Test already paid within the interval | Only if documentation proves a new indication |
| Medical necessity | Diagnosis code doesn’t match LCD | Yes, with a stronger clinical letter |
Specific Blood Tests Most Often Denied Under Medicare
The list below covers the assays that produce the highest volume of patient complaints and the most recurring balance bills. Inclusion here doesn’t mean every draw is denied, only that denials cluster around these panels when the clinical picture is thin.
- Vitamin D (25-hydroxy): Covered only for documented deficiency, malabsorption syndromes, specific bone disorders, or chronic kidney disease, not for general wellness screening.
- Testosterone panels: Paid when used to evaluate hypogonadism, but routinely denied for age-related fatigue, low libido screening, or general wellness panels.
- Hemoglobin A1C: Covered up to twice yearly for diabetes monitoring, once every 12 months for non-diabetic screening, and denied inside those windows.
- Thyroid-stimulating hormone (TSH): Requires a clinical indication such as hypothyroidism follow-up, fatigue plus weight changes, or thyroid medication monitoring; pure screening in asymptomatic patients is excluded.
- Heavy-metal screenings: Lead, mercury, arsenic, and cadmium panels are covered only with documented occupational exposure or symptoms of toxicity, not as part of a routine workup.
- Tumor markers: PSA outside USPSTF guidelines, CA-125 for average-risk ovarian screening, and CEA outside colorectal cancer surveillance all deny routinely.
- Lipid panels: A five-year screening interval applies to low-risk adults; shorter intervals require established cardiovascular disease or treatment monitoring.
- Broad allergy IgE panels: Specific IgE or skin testing for documented allergic conditions is covered; large multi-allergen panels without a defined exposure history are not.
The annual wellness visit exception
Two preventive visits unlock a specific list of screenings with zero cost-sharing: the one-time Welcome to Medicare exam and the Annual Wellness Visit that follows. Those lists do not include general blood work. If your provider orders a CBC or metabolic panel during the visit, expect the lab to bill those separately, and expect Medicare to apply the usual coverage rules. A cardiovascular screening blood test for lipid levels is covered once every five years as part of preventive benefits, but only the lipid components, not a full metabolic or thyroid panel added for convenience.
Because those exclusions translate directly into what the lab eventually bills the patient, the cost side of the equation deserves equal scrutiny.
What Beneficiaries Pay When a Blood Test Is Not Covered
Denied outpatient lab work is billed at the lab’s private fee schedule, which can run from roughly $15 for a simple TSH to several hundred dollars for a specialty hormone or genetic panel. National diagnostics chains publish cash prices online, and those numbers are usually the closest estimate of what you’ll owe when Medicare pays nothing.
For tests Medicare does cover, the cost structure is predictable. You first meet the annual Part B deductible before coinsurance applies, then pay 20% of the Medicare-approved amount for the lab work. Medicare Advantage enrollees face in-network lab restrictions and varying copays that can run higher or lower than Original Medicare, depending on the plan’s formulary of approved tests and whether the lab is in-network. Medigap plans absorb Part B coinsurance for covered tests but generally do not pay for services Medicare itself excludes, so the gap is structural, not just a deductible problem.
Warning: Non-covered tests bypass the Part B deductible entirely. Paying $300 for an excluded panel does not move you closer to meeting your annual deductible; it is a direct out-of-pocket obligation from day one.
| Coverage Status | What You Owe | Does It Apply to the Deductible? |
|---|---|---|
| Covered test, deductible not met | Full Medicare-approved rate up to the deductible | Yes |
| Covered test, deductible met | 20% coinsurance | Already met |
| Non-covered test | Lab’s full private rate | No |
| Frequency-limited repeat | Lab’s full private rate | No |
Confirming Coverage Before the Draw
The cheapest denied claim is the one you prevent. A short pre-draw conversation with the ordering office and the lab can convert a potential $300 surprise into a covered test or a documented out-of-pocket estimate you can plan for.
The pre-draw checklist
- Confirm the diagnosis code: Ask the ordering provider to put a specific ICD-10 code on the requisition that matches an LCD or NCD indication for the test being drawn.
- Request an Advance Beneficiary Notice: The lab can issue an ABN when it has reason to believe Medicare will deny the claim, converting the charge into a written estimate you sign in advance.
- Verify CLIA certification and assignment: Make sure the lab holds Clinical Laboratory Improvement Amendments certification and accepts Medicare assignment, which caps what it can bill you for covered services.
- Check the contractor’s LCD list: The Medicare Administrative Contractor for your state publishes which diagnoses qualify for each test; a five-minute search can save a five-month appeal.
- Call 1-800-MEDICARE: For ambiguous cases, the hotline can confirm whether a specific test is covered for a specific indication in your region.
- Medicare Advantage members: Confirm the lab is in-network and that any required prior authorization is on file before scheduling the draw.
Appealing a Denied Blood Test Claim and Closing the Gap
A denial on the Medicare Summary Notice is not the end of the conversation. The appeals process has five levels, and the first two are paper-only and free.
Reading the denial reason
Each line item on the MSN carries a Claim Adjustment Reason Code and a Remittance Advice Remark Code that tells you exactly why Medicare refused to pay. “CO-50” usually means non-covered service, “CO-97” points to a bundling or frequency edit, and “CO-16” flags missing documentation. Identifying the right code before you appeal lets you tailor the supporting letter to the exact reason Medicare gave.
The appeals pathway
File a redetermination request within 120 days of the denial date, attaching the doctor’s letter of medical necessity, the original requisition, and any clinical notes that justify the test. If the redetermination is unfavorable, escalate to a reconsideration by a Qualified Independent Contractor, then to an Administrative Law Judge hearing, then to the Medicare Appeals Council, and finally to federal court. Most successful appeals hinge on a one-page letter from the ordering physician explaining why the test was necessary for diagnosis or treatment of a documented condition, supported by chart notes.
Closing the long-term gap
Patterns of denial suggest a structural problem. A Medigap plan can absorb Part B coinsurance for covered tests but will not pay for excluded services, so adding a Medicare Advantage plan with richer lab benefits or applying for Medicaid as a dual-eligible beneficiary can reduce future exposure for the same set of tests. Tracking which tests your doctors order most often, and which codes get denied, gives you leverage to ask for stronger documentation at the point of order rather than after the bill arrives.
Bottom Line
Medicare covers blood work that documents or treats a real condition and denies work that looks like screening, repeats inside a frequency window, or arrives without matching clinical justification. The fastest way to control your out-of-pocket cost is to confirm the diagnosis code, the lab’s Medicare status, and the contractor’s coverage rules before the needle goes in, then appeal any denial with a one-page medical-necessity letter within 120 days.
FAQ
What blood tests are not covered by Medicare?
Vitamin D screening in asymptomatic adults, testosterone panels for general fatigue, heavy-metal panels without documented exposure, broad allergy IgE panels, and tumor markers such as CA-125 or PSA used outside USPSTF guidelines are the most commonly denied. Any test that lacks a diagnosis code linking it to a covered indication faces the same risk.
Does Medicare pay for routine blood work?
Original Medicare covers lab work ordered to diagnose or treat a specific condition, plus a narrow set of preventive screenings such as the cardiovascular blood test every five years. Routine wellness panels without a clinical indication are not paid, and the lab will bill you at its private rate.
How much do blood tests cost if Medicare does not cover them?
Denied labs bill at their published fee schedule, which ranges from roughly $15 for a simple TSH to several hundred dollars for specialty hormone or genetic panels. Cash-pay prices posted by national lab chains are a reliable proxy for what you will owe.
Are genetic blood tests covered by Medicare?
An NCD or LCD must list a payable indication before Medicare will pay for a genetic test, and BRCA testing qualifies only for beneficiaries whose personal or family history meets those specific criteria. Consumer-grade genetic panels ordered for general wellness are typically excluded.
Does Medicare cover blood work during the annual wellness visit?
The Annual Wellness Visit itself is covered without cost-sharing, but the lab work it may prompt is billed separately and follows the usual coverage rules. A cardiovascular screening lipid panel once every five years is covered as a preventive service; anything beyond that is treated as a diagnostic or screening test.
Can a doctor order blood tests that Medicare will not pay for?
Yes. A physician can order any test deemed clinically appropriate, and Medicare may still decline to pay if the documentation does not meet medical-necessity requirements. The Advance Beneficiary Notice is the tool that lets the lab warn you about that risk in advance.
